A Phase IIIb Clinical Study to Assess the Efficacy and Safety of GZR4 in Subjects With Type 2 Diabetes Mellitus Treated With Basal Insulin
Clinical trial NCT07165223 · RECRUITING
Trial details
- NCT number
- NCT07165223
- Sponsor
- Gan & Lee Pharmaceuticals.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-17
- Primary completion
- 2026-11-10
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.